Web Results

Dr. Vivian P. Bykerk, BSc, MD, FRCPC, Rheumatologist - HSS.edu

www.hss.edu/physicians_bykerk-vivian.asp

"As rheumatologists, we want to see patients with new onset rheumatoid arthritis ideally as soon as possible." said Dr. Bykerk. "Patients often don't get to us for ...

Update on the safety profile of certolizumab pegol in rheumatoid ...

www.ncbi.nlm.nih.gov/pubmed/24092417

Oct 3, 2013 ... Bykerk VP(1), Cush J(2), Winthrop K(3), Calabrese L(4), Lortholary O(5), ... (1) Hospital for Special Surgery, New York, New York, USA. ... compared to placebo- treated patients in RCT (IR 5.61/100 PY vs 1.35/100 PY, odds ratio (OR) 4.35, 95 % CI 0.65 to 29.30). ... Research Support, Non-U.S. Gov't; Review ...

Serum 14-3-3η is a novel marker that complements current ... - NCBI

www.ncbi.nlm.nih.gov/pubmed/25128504

Aug 15, 2014 ... Maksymowych WP(1), Naides SJ(2), Bykerk V(2), Siminovitch KA(2), van Schaardenburg ... Boston, Massachusetts, USA; Vrije Universiteit University Medical Center; ... Comparative Study; Research Support, Non-U.S. Gov't ...

Answers About Rheumatoid Arthritis, Part 3 - The New York Times

www.nytimes.com/2013/08/01/booming/answers-about-rheumatoid-arthritis-part-3.html

Aug 1, 2013 ... Dr. Vivian P. Bykerk, rheumatologist. Diet vs. Medication, Revisited. Q. I was told I had .... You can reach us by e-mail at booming@nytimes.com.

www.ask.com/youtube?q=United States of America v. Bykerk&v=9vdJQ6SR5WA
Apr 5, 2014 ... Today's interview features Dr. Vivian Bykerk, rheumatologist and Director ... Dr. Bykerk shares with us some differences in treating patients with ...

Whitey: United States of America v. James J. Bulger - CNN.com

www.cnn.com/shows/whitey

CNN Films' "Whitey: United States of America v. James J. Bulger" details the capture and conviction of the notorious Boston gangster.

Delay in receiving rheumatology care leads to long-term harm ...

onlinelibrary.wiley.com/doi/10.1002/art.27691/abstract

Delay in receiving rheumatology care leads to long-term harm. Vivian Bykerk<sup>1,†</sup> and; Paul Emery2,‡,*. Version of Record online: 30 NOV 2010.

Patient Engagement from the Researcher's Perspective

www.rheumatology.org/Portals/0/Files/Nothing-About Us-Without-Us-Engaging-Patients-ARHP-Webinar.pdf

Feb 28, 2016 ... Nothing About Us Without Us: ... Bykerk V, Furst D, Leong A, et al. ... Bingham CO 3rd, Alten R, Bartlett SJ, Bykerk VP, Brooks PM, Choy E, ...

Global Academy for Medical Education: Dosage Reduction and ...

www.globalacademycme.com/dosage-reduction-and-withdrawal-of-biologic-therapy-in-ra.html

ABOUT US. Links ... vs long-standing disease), previous treatments and outcomes, current therapeutic regimen, current ... Emery P, Burmester G, Bykerk V, et al.

Reduction of Disease Burden on Workplace and Household ...

acrabstracts.org/abstract/reduction-of-disease-burden-on-workplace-and-household-productivity-following-52-weeks-of-treatment-with-certolizumab-pegol-in-combination-with-methotrexate-in-dmard-naive-patients-with-active-severe/

VP Bykerk<sup>1</sup>, Clifton Bingham<sup>2</sup>, Gerd Burmester<sup>3</sup>, Daniel E. Furst<sup>4</sup>, Xavier Mariette<sup>5</sup>, ... both early and established RA pts with >2 wks of paid work (mean 13.3 vs ... 2,Abbvie, 5,Actelion Pharmaceuticals US, 5,Amgen, 5,Bristol-Myers Squibb, ...

More Info

Comparison of tocilizumab as monotherapy or with add-on disease ...

www.ncbi.nlm.nih.gov

Jan 22, 2015 ... Bykerk VP(1), Östör AJ, Alvaro-Gracia J, Pavelka K, Román Ivorra JA, ... Special Surgery, 535 East 70th Street, New York, NY, 10021, USA, bykerkv@hss.edu. ... 1.49 for tocilizumab monotherapy vs -3.43 ± 1.43 for combination therapy; ... Clinical Trial; Comparative Study; Research Support, Non-U.S. Gov't ...

Vivian Bykerk | Medicine - Rheumatology | Weill Cornell Medicine

weillcornell.org

Personal Statement. " As rheumatologists, we want to see patients with new onset rheumatoid arthritis ideally as soon as possible.Patients often don't get to us ...

Cecil D. Bykerk | ARIAS•U.S.

www.arias-us.org

Attorney: No. Education: Fellow of the Society of Actuaries, Member of the American Academy of Actuaries, Fellow of the Conference of Consulting Actuaries, ...